T1/T2 glottic cancer managed by external beam radiotherapy: The influence of pretreatment hemoglobin on local control

被引:150
|
作者
Warde, P
O'Sullivan, B
Bristow, RG
Panzarella, T
Keane, TJ
Gullane, PJ
Witterick, IP
Payne, D
Liu, FF
McLean, M
Waldron, J
Cummings, BJ
机构
[1] Univ Toronto, Princess Margaret Hosp, Dept Radiat Oncol, Toronto, ON M5G 2M9, Canada
[2] Univ Toronto, Princess Margaret Hosp, Dept Biostat, Toronto, ON M5G 2M9, Canada
[3] Univ Toronto, Princess Margaret Hosp, Dept Surg Oncol, Toronto, ON M5G 2M9, Canada
关键词
glottic cancer; hemoglobin; local control; radiation therapy;
D O I
10.1016/S0360-3016(98)00062-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Pretreatment hemoglobin (Hb) level has been reported to be an important prognostic factor for local control and survival in various malignancies. However, in many settings, the adverse effect of a low Hb may be related to more advanced disease. The purpose of this analysis was to assess the influence of pretreatment Hb on local control in a large series of patients with a localized cancer (T1/T2 glottic cancer, AJCC 1992) treated in a standard fashion. Materials and Methods: Between January 1981 and December 1989, 735 patients (median age 63; 657 males, 78 females) with T1/T2 glottic cancer were treated with radiation therapy (RT). The standard RT prescription was 50 Gy in 20 fractions over 4 weeks (97% of patients). Factors studied for prognostic importance for local failure included pretreatment Hb, age, sex, T category, anterior commissure involvement, subglottic extension, and tumor bulk (presence of visible tumor vs. subclinical disease). Results: With a median follow up of 6.8 years (range 0.2-14.3), 131 patients have locally relapsed for an actuarial 5-year relapse-free rate of 81.7%. The 5-year actuarial survival was 75.8%. The mean pretreatment hemoglobin level was 14.8 g/dl and was similar in all prognostic categories. On multivariate analysis, using the Cox proportional hazards model, pretreatment Hb predicted for local failure after RT. The hazard ratio (HR) for relapse was calculated for various Hb levels. For example, the HR for a Hb of 12 g/dl vs, a Hb of 15 g/dl was 1.8 (95% confidence interval 1.2-2.5). Previously established factors, including gender, T category, subglottic extension, as well as tumor bulk, were also prognostically important for local control. Conclusions: This analysis, in a large number of similarly treated patients, indicates that pretreatment Hb is an independent prognostic factor for local control in patients with T1/T2 carcinoma of the glottis treated with RT. The underlying biology of this observation needs to be explored, and using this information, it may be possible to develop strategies to improve treatment outcome. (C) 1998 Elsevier Science Inc.
引用
收藏
页码:347 / 353
页数:7
相关论文
共 50 条
  • [21] Hyperfractionated radiotherapy for T2 glottic cancer for preservation of the larynx
    Ichiro Tateya
    Shigeru Hirano
    Hisayoshi Kojima
    Koichi Omori
    Kazuhiko Shoji
    Michihide Mitsumori
    Yasushi Nagata
    Juichi Ito
    European Archives of Oto-Rhino-Laryngology and Head & Neck, 2006, 263 : 144 - 148
  • [22] Hyperfractionated radiotherapy for T2 glottic cancer for preservation of the larynx
    Tateya, I
    Hirano, S
    Kojima, H
    Omori, K
    Shoji, K
    Mitsumori, M
    Nagata, Y
    Ito, J
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2006, 263 (02) : 144 - 148
  • [23] Utility of Sonography for Evaluation of Clinical T1 and T2 Glottic Carcinoma
    Kuribayashi, Shigehiko
    Miyashita, Tsuguhiro
    Nakamizo, Munenaga
    Yagi, Toshiaki
    Kumita, Shinichiro
    JOURNAL OF ULTRASOUND IN MEDICINE, 2009, 28 (11) : 1429 - 1440
  • [24] Glottic carcinoma stage T1 radiotherapy
    Dickie, G. J.
    Askew, J.
    Tripcony, L.
    Ha, T.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S501 - S501
  • [25] Local Excision of T1 and T2 Rectal Cancer: Proceed With Caution
    Elmessiry, Mohamed M.
    Maya, Antonio
    da Silva, Giovanna
    Wexner, Steven
    Berho, Mariana
    GASTROENTEROLOGY, 2013, 144 (05) : S1096 - S1096
  • [26] Prognostic factors of local control after radiotherapy in T1 glottic and supraglottic carcinoma of the larynx
    Carl, J
    Andersen, LJ
    Pedersen, M
    Greisen, O
    RADIOTHERAPY AND ONCOLOGY, 1996, 39 (03) : 229 - 233
  • [27] Local excision of T1 and T2 rectal cancer: proceed with caution
    Elmessiry, M. M.
    Van Koughnett, J. A. M.
    Maya, A.
    DaSilva, G.
    Wexner, S. D.
    Bejarano, P.
    Berho, M.
    COLORECTAL DISEASE, 2014, 16 (09) : 703 - 709
  • [28] Utilization, Efficacy and Toxicity of Hypofractionation for T1/T2 Glottic Cancer Outside of Academic Centers
    Ahamad, A.
    Salenius, S.
    Ross, R.
    Fernandez, E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E317 - E318
  • [29] Primary radiotherapy of T1 and T2 glottic carcinoma - Analysis of treatment results and prognostic factors in 223 patients
    Klintenberg, C
    Lundgren, J
    Adell, G
    Tytor, M
    NorbergSpaak, L
    Edelman, R
    Carstensen, JM
    ACTA ONCOLOGICA, 1996, 35 : 81 - 86
  • [30] Outcomes of T1 and T2 Glottic Carcinoma Treated with Definitive Radiotherapy at Cleveland Clinic: A 20 Year Experience
    Khan, M. K.
    Koyfman, S.
    Hunter, G. H.
    Reddy, C. A.
    Saxton, J. P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S418 - S419